More troubles for key competitor Philips/Respironics suggests there could be more momentum shifting in ResMed’s favour
Michael Gable of Fairmont Equities is signaling momentum seems to have turned for Charter Hall shares, with a fresh Buy signal about to be triggered
ResMed’s December quarter showed long-awaited margin improvement and relieved market fears of the impact of weight-loss drugs
Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements
In response to a broker’s negative assessment, Judo Capital has provided a surprise trading update that significantly exceeded expectations
Michael Gable of Fairmont Equities observes market dynamics for ResMed have changed for the better with price action suggesting higher prices are on the cards
Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements
A glance through the latest expert views and predictions about commodities: While the long-term outlook for copper is unchanged, there is potential for near-term downside, while brokers believe long-term fundamentals for iron ore are largely unchanged
FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Today’s idea is Ansell
FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Today’s idea concerns Australian banks
